👉 where we catch you up on the week's #NephJC chat in 10 tweets
The topic at hand was Plasma Exchange and Vasculitis: the infamous debate of to PLEX or not to PLEX in AAV
Check out this thread to see if you change your mind on this comPLEX topic 👇
What did I miss?
PLEX, with its plausible biological rationale, has been in the center of debate for management of AAV since the 1980s, with several RCTs in favor of PLEX or against it
🔸️An updated meta-analysis which included the PEXIVAS results was discussed
1 tweet methods
✅ updated systematic review & meta-analysis
✅ RCTs of patients with AAV or pauci-immune RPGN receiving PLEX and ≥12mo. follow-up
✅ Outcome measures were at least one of: mortality, ESKD, serious infection, relapse, AE or health-related QoL
1 tweet results
🔹9 RCTs (n, 1060)
❌No effect on all-cause mortality
RR risk 0.90 (95% CI 0.64 - 1.27)
🔹7 RCTs (n, 999)
⬇️ risk of ESKD at 12 mo.
RR 0.62 (0.39 - 0.98)
❌No effect long-term
🔹4 RCTs (n, 908)
⬆️ risk of serious infections over 12 mo.
RR 1.27 (1.08 - 1.49)
A figure paints 1000 words
PLEX and ESKD at 12-months’ follow-up
Give me something clever to say
“This meta-analysis demonstrates the unexpected, differential effects of PLEX on ESKD compared with all-cause mortality, which dramatically reduced the power of PEXIVAS to reliably estimate the benefits of PLEX using a composite outcome.”
Chat consensus?
1️⃣ Most would continue to use PLEX in patients with PAH
2️⃣ Most wouldn't consider PLEX with a creatinine level <500 µmol/L
3️⃣ Involving patients in decision making and choose patients with ⬆️ risk of ESKD and ⬇️ risk of infections
Quote of the fortnight!
"@NephJC My favorite quote when researching for this summary #NephJC"
✳️ Welcome to #TenTweetNephJC, where we catch you up on the week's #NephJC chat in 10 tweets ✳️
The topic at hand was diuretic resistance, specifically compensatory post-diuretic sodium reabsorption (CPDSR). Let’s walk you through how it all flowed 💧
What did I miss?
We teach medical students that diuretic resistance occurs in large part due to CPDSR. While this has been validated in healthy individuals, does this hold true in patients w/ acute decomp heart failure (ADHF)?
Enter the study in question pubmed.ncbi.nlm.nih.gov/34529781/
1 tweet methods
✅Single center, prospective, observational study, with a randomized sub-cohort
✅Evaluating mechanisms of diuretic resistance in patients with ADHF on IV loops 💉
✅Supervised urine collection pre and post diuresis
✅Primary outcome = level of CPDSR
This weeks #TenTweetNephJC makes us sad - does taking regular acetaminophen (paracetamol) cause hypertension?
Find out below in this rapid review of the Scottish trial, as we catch up on the #NephJC take on things 👇
What did I miss?
Observational trials suggest that acetaminophen increases BP, but (unlike NSAIDs) the widespread impression remains of a safe first-line therapy for chronic pain. The largest previous RCT had n=33.
✳️ 10 tweets to catch-up on the most recent #NephJC ✳️
This week - when is the ideal time to start dialysis in progressive chronic kidney disease?
Later starts lower the burden on patients & use of healthcare resources, but what’s the trade-off?
What did I miss?
Previous observational studies analysing outcomes by eGFR at point of dialysis initiation suffered from immortal time bias, survivor bias, and lead time bias. This trial used clever new statistical methods to avoid these flaws!
Cochrane & KDIGO recommend children with steroid-sensitive nephrotic syndrome (SSNS) take low dose pred during upper resp tract infection (URTI) to ⬇️relapse risk, based on 4 small studies - does this hold up in a big RCT?
What did I miss?
We actually covered two studies this week in collaboration with @ipnajc but we can’t do both in #TenTweetNephJC! We’ll focus on the PREDNOS-2 trial.